Kawasaki, Japan

Hidenari Sakaguchi

This inventor holds 1 USPTO granted patent. Top assignee: Showa Yakuhin Kako Co., Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidenari Sakaguchi. Retrieved from https://idiyas.com/inventor/hidenari-sakaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 88(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hidenari Sakaguchi: Innovator in Pharmaceutical Compositions

Introduction

Hidenari Sakaguchi is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions.

Latest Patents

Sakaguchi holds 1 patent for his invention titled "Minocycline-containing compositions." The objective of this patent is to provide a stable pharmaceutical composition for topical administration that includes minocycline as an active ingredient. This innovative composition comprises minocycline or a physiologically acceptable salt thereof in an oleaginous base, ensuring effective delivery and stability.

Career Highlights

Sakaguchi is associated with Showa Yakuhin Kako Co., Ltd., a company known for its advancements in pharmaceutical products. His work has contributed to the development of effective treatments in the medical field.

Collaborations

Some of his notable coworkers include Kazuhiro Ono and Ikuto Hayakawa, who have collaborated with him on various projects within the company.

Conclusion

Hidenari Sakaguchi's contributions to pharmaceutical compositions highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…